SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 7,827.64 |
| Enterprise Value ($M) | 5,611.82 |
| Book Value ($M) | 5,187.20 |
| Book Value / Share | 7.27 |
| Price / Book | 1.51 |
| NCAV ($M) | 4,750.32 |
| NCAV / Share | 6.66 |
| Price / NCAV | 1.65 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.03 |
| Return on Assets (ROA) | -0.02 |
| Return on Equity (ROE) | -0.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 33.47 |
| Current Ratio | 33.47 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5,000.06 |
| Assets | 5,436.94 |
| Liabilities | 249.74 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 29.05 |
| Operating Income | -1,113.68 |
| Net Income | -171.98 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -839.45 |
| Cash from Investing | -1,766.29 |
| Cash from Financing | -1,219.79 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Ramaswamy Vivek | 11.63 | 1.84 | |
| 13G/A | Viking Global Investors Lp | 6.40 | -14.95 | |
| 13G/A | QVT Financial LP | 9.22 | -1.39 | |
| 13G/A | Sb Investment Advisers (uk) Ltd | 8.50 | -15.03 | |
| 13G | Fmr Llc | 6.64 | ||
| 13G/A | Vanguard Group Inc | 5.63 | 0.00 | |
| 13G | BlackRock, Inc. | 5.70 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,035,343 | 5,668,043 | 18.27 | |
| 1,200,200 | 6,214,421 | 19.31 | |
| 876,880 | 3,279,937 | 26.73 | |
| 554,909 | 3,201,708 | 17.33 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RIGL – Rigel Pharmaceuticals, Inc. | RLMD – Relmada Therapeutics, Inc. |
| RLYB – Rallybio Corporation | RPRX – Royalty Pharma plc |
| RPTX – Repare Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io